VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 452 filers reported holding VANECK VECTORS ETF TR in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $81,000 | +19.1% | 2,117 | 0.0% | 0.02% | +19.0% |
| Q4 2021 | $68,000 | -31.3% | 2,117 | -37.2% | 0.02% | -38.2% |
| Q3 2021 | $99,000 | -13.9% | 3,373 | 0.0% | 0.03% | -15.0% |
| Q2 2021 | $115,000 | +8.5% | 3,373 | +3.8% | 0.04% | -2.4% |
| Q1 2021 | $106,000 | -7.8% | 3,251 | +1.8% | 0.04% | -19.6% |
| Q4 2020 | $115,000 | +11.7% | 3,193 | +21.8% | 0.05% | 0.0% |
| Q3 2020 | $103,000 | +8.4% | 2,621 | +1.5% | 0.05% | 0.0% |
| Q2 2020 | $95,000 | +126.2% | 2,583 | +42.2% | 0.05% | +82.1% |
| Q1 2020 | $42,000 | +7.7% | 1,817 | +37.2% | 0.03% | +27.3% |
| Q4 2019 | $39,000 | +14.7% | 1,324 | +4.4% | 0.02% | +10.0% |
| Q3 2019 | $34,000 | -46.0% | 1,268 | -48.8% | 0.02% | -47.4% |
| Q2 2019 | $63,000 | +43.2% | 2,475 | +27.1% | 0.04% | +35.7% |
| Q1 2019 | $44,000 | +76.0% | 1,947 | +61.3% | 0.03% | +55.6% |
| Q4 2018 | $25,000 | +4.2% | 1,207 | +0.5% | 0.02% | +12.5% |
| Q3 2018 | $24,000 | +4.3% | 1,201 | +16.8% | 0.02% | -5.9% |
| Q2 2018 | $23,000 | 0.0% | 1,028 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $23,000 | – | 1,028 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |